Displaying results 133 - 144 of 222
General Hepatology
Arsenic as a risk factor for metabolic-associated steatotic liver disease (MASLD): A mechanistic study

Arsenic as a risk factor for metabolic-associated steatotic liver disease (MASLD): A mechanistic study

ePosters
View
General Hepatology
Circulating CEACAM1 as a biomarker for hepatic steatosis in a metabolic context: Insights from the Portuguese PREVADIAB2 study

Circulating CEACAM1 as a biomarker for hepatic steatosis in a metabolic context: Insights from the Portuguese PREVADIAB2 study

ePosters
View
General Hepatology
HK3, a novel MASH drug with profound anti-obesity action

HK3, a novel MASH drug with profound anti-obesity action

ePosters
View
General Hepatology
The vitamin E conundrum: Should you still be using it for metabolic dysfunction-associated steatotic liver disease (MASLD)

The vitamin E conundrum: Should you still be using it for metabolic dysfunction-associated steatotic liver disease (MASLD)

ePosters
View
General Hepatology
Microvascular complications of type 2 diabetes mellitus in patients with concomitant metabolic dysfunction-associated steatotic liver disease in primary care, a prospective cohort study

Microvascular complications of type 2 diabetes mellitus in patients with concomitant metabolic dysfunction-associated steatoti...

ePosters
View
General Hepatology
A serial investigation to develop herbal-derived therapeutics targeting MASLD and metabolic syndrome using Amomum Xanthioides

A serial investigation to develop herbal-derived therapeutics targeting MASLD and metabolic syndrome using Amomum Xanthioides

ePosters
View
General Hepatology
Paving the way for MASH screening of high-risk patients in primary and secondary care

Paving the way for MASH screening of high-risk patients in primary and secondary care

ePosters
View
General Hepatology
The dietitians role in the pre-operative workup for patients undergoing laparoscopic surgery of the upper GIT

The dietitians role in the pre-operative workup for patients undergoing laparoscopic surgery of the upper GIT

ePosters
View
General Hepatology
FLAME model: validation of a tool incorporating alpha-glutathione-s-transferase serum levels for predicting advanced fibrosis and cardiovascular events in MASLD

FLAME model: validation of a tool incorporating alpha-glutathione-s-transferase serum levels for predicting advanced fibrosis ...

ePosters
View
General Hepatology
Cholesterol exacerbates the pathophysiology of metabolic dysfunction-associated steatohepatitis by upregulating Hypoxia-Inducible Factor 1 and modulating microcirculatory dysfunction

Cholesterol exacerbates the pathophysiology of metabolic dysfunction-associated steatohepatitis by upregulating Hypoxia-Induci...

ePosters
View
General Hepatology
Normal fibrosis-4 values do not exclude advanced fibrosis in 15 of patients with metabolic dysfunction-associated steatotic liver disease

Normal fibrosis-4 values do not exclude advanced fibrosis in 15 of patients with metabolic dysfunction-associated steatotic li...

ePosters
View
General Hepatology
A randomized controlled study of daily aspirin to reduce fibrosis progression in metabolic dysfunction-associated steatotic liver disease

A randomized controlled study of daily aspirin to reduce fibrosis progression in metabolic dysfunction-associated steatotic li...

ePosters
View